BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20169165)

  • 1. SIRT1 negatively regulates the mammalian target of rapamycin.
    Ghosh HS; McBurney M; Robbins PD
    PLoS One; 2010 Feb; 5(2):e9199. PubMed ID: 20169165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR.
    Liu M; Wilk SA; Wang A; Zhou L; Wang RH; Ogawa W; Deng C; Dong LQ; Liu F
    J Biol Chem; 2010 Nov; 285(47):36387-94. PubMed ID: 20851890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy.
    García-Aguilar A; Guillén C; Nellist M; Bartolomé A; Benito M
    Biochim Biophys Acta; 2016 Nov; 1863(11):2658-2667. PubMed ID: 27542907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin 1 independent effects of resveratrol in INS-1E β-cells.
    Erdogan CS; Mørup-Lendal M; Dalgaard LT; Vang O
    Chem Biol Interact; 2017 Feb; 264():52-60. PubMed ID: 28108221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes.
    Miyazaki M; McCarthy JJ; Esser KA
    FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1 Regulates the Inflammatory Response of Vascular Adventitial Fibroblasts through Autophagy and Related Signaling Pathway.
    Wang WR; Li TT; Jing T; Li YX; Yang XF; He YH; Zhang W; Lin R; Zhang JY
    Cell Physiol Biochem; 2017; 41(2):569-582. PubMed ID: 28214861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice.
    Liu Z; Gan L; Liu G; Chen Y; Wu T; Feng F; Sun C
    J Lipid Res; 2016 Aug; 57(8):1373-81. PubMed ID: 27317762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
    Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
    J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.
    Matthew EM; Hart LS; Astrinidis A; Navaraj A; Dolloff NG; Dicker DT; Henske EP; El-Deiry WS
    Cell Cycle; 2009 Dec; 8(24):4168-75. PubMed ID: 20054236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy.
    Qin L; Wang Z; Tao L; Wang Y
    Autophagy; 2010 Feb; 6(2):239-47. PubMed ID: 20104019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR.
    Dere R; Wilson PD; Sandford RN; Walker CL
    PLoS One; 2010 Feb; 5(2):e9239. PubMed ID: 20169078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.
    Nin V; Escande C; Chini CC; Giri S; Camacho-Pereira J; Matalonga J; Lou Z; Chini EN
    J Biol Chem; 2012 Jul; 287(28):23489-501. PubMed ID: 22553202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts.
    Li P; Liang ML; Zhu Y; Gong YY; Wang Y; Heng D; Lin L
    World J Gastroenterol; 2014 Apr; 20(16):4648-61. PubMed ID: 24782617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.
    Li G; Rivas P; Bedolla R; Thapa D; Reddick RL; Ghosh R; Kumar AP
    Cancer Prev Res (Phila); 2013 Jan; 6(1):27-39. PubMed ID: 23248098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.
    Hahn-Windgassen A; Nogueira V; Chen CC; Skeen JE; Sonenberg N; Hay N
    J Biol Chem; 2005 Sep; 280(37):32081-9. PubMed ID: 16027121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
    Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
    J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia.
    Wang P; Guan YF; Du H; Zhai QW; Su DF; Miao CY
    Autophagy; 2012 Jan; 8(1):77-87. PubMed ID: 22113203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2.
    Huang J; Dibble CC; Matsuzaki M; Manning BD
    Mol Cell Biol; 2008 Jun; 28(12):4104-15. PubMed ID: 18411301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.